NCT03118570Phase 2Completed

A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804

Study sponsor: Ultragenyx Pharmaceutical Inc · RARE

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2019-10-01Actual
Enrollment · participants112Actual
Source updated2023-07-05Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.